Samra Turajlić Was Named New Director of the CRUK Manchester Institute

Cancer Research UK Manchester Institute welcomes Professor Samra Turajlić as its new Institute Director.

Background

• Consultant Medical Oncologist at The Christie NHS Foundation Trust
• Group Leader of the Cancer Dynamics research group

Research Focus

Professor Turajlić's work encompasses basic, translational, and clinical cancer research. She has led numerous pioneering studies that have significantly advanced our understanding of cancer biology and treatment.

Key Roles and Affiliations

• Chief Investigator of translational studies into melanoma and kidney cancer (TRACERx)
• Research goal: Develop an evolutionary understanding of cancer for patient benefit
• Member of the NCRI Bladder and Renal Cancer Clinical Studies Group
• ESMO – European Society for Medical Oncology Faculty member for genitourinary cancers
• Scientific Committee member for ESMO, Molecular Analysis for Personalised Therapy, Kidney Cancer Association, and EORTC-NCI-AACR Symposia

Community Involvement

• Trustee of the Kidney Cancer Support Network and Melanoma Focus
• Senior Editor at Macmillan Cancer Support